RECURSION PHARMACEUTICALS, INC. (RXRX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.47B | +1.8% |
| 2024 | $1.45B | +121.6% |
| 2023 | $653.70M | -6.8% |
| 2022 | $701.29M | +14.9% |
| 2021 | $610.35M | +104.4% |
| 2020 | $298.58M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.47B | +1.8% |
| 2024 | $1.45B | +121.6% |
| 2023 | $653.70M | -6.8% |
| 2022 | $701.29M | +14.9% |
| 2021 | $610.35M | +104.4% |
| 2020 | $298.58M | — |